ArticleFrontiers in pharmacology2026
UHPLC-Q/TOF-MS-based differential metabolite screening and origins classification of Codonopsis Radix.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Codonopsis Radix (CR), also known as Dangshen, is a renowned plant native to China, highly valued for its unique medicinal properties. However, due to the existence of numerous closely related origins and the similarities in their interspecies traits, microscopic characteristics, and physicochemical properties, different origins of CR have been circulating in the market, posing significant challenges for standardizing its medicinal use. Therefore, establishing an accurate identification method is crucial for advancing research on CR and ensuring its proper utilization. Methods: In this study, a UHPLC-Q/TOF-MS analysis method was developed to identify differential metabolites among three origins of CR using one-way analysis of variance (ANOVA). The metabolites were distinguished based on the response ratios of the differential metabolites. Additionally, a neural network (NN) model was established to validate the classification capability. Results: Metabolomic results revealed that among the 56 identified metabolites, 29 differential metabolites were screened out. Notably, the response ratios of codonopyrrolidium A, codonopyrrolidium D, tryptophan, and codonopsinol A against 3'-hydroxy codonopyrrolidium B exhibited significant differences among the three origins. Verification experiments demonstrated that the NN model achieved a prediction accuracy of 100%, with a confidence measure exceeding 0.98. Discussion: This study established two methods for identifying the origins of CR: a simple and rapid ratio method, and a highly accurate NN model. It demonstrated the feasibility of identifying the origins of CR through cross-validation, providing new insights and methodologies for the origin identification of multi-origin traditional Chinese medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.